Literature DB >> 22723412

Influenza: options to improve pandemic preparation.

Rino Rappuoli1, Philip R Dormitzer.   

Abstract

Science and society have been struggling to find a way to protect humankind from recurring epidemics and pandemics of influenza. Here, we review the options available in the short term and also briefly address the solutions that research may make available in the long term.

Mesh：

Substances：

Year:  2012        PMID： 22723412     DOI： 10.1126/science.1221466

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  34 in total

1.  Bringing influenza vaccines into the 21st century.

Authors:  Ethan C Settembre; Philip R Dormitzer; Rino Rappuoli
Journal:  Hum Vaccin Immunother       Date:  2013-12-30       Impact factor: 3.452

2.  Evolution and control of H5N1. A better understanding of the evolution and diversity of H5N1 flu virus and its host species in endemic areas could inform more efficient vaccination and control strategies.

Authors:  Yohei Watanabe; Madiha S Ibrahim; Kazuyoshi Ikuta
Journal:  EMBO Rep       Date:  2013-01-11       Impact factor: 8.807

3.  A chemical free, nanotechnology-based method for airborne bacterial inactivation using engineered water nanostructures.

Authors:  Georgios Pyrgiotakis; James McDevitt; Andre Bordini; Edgar Diaz; Ramon Molina; Christa Watson; Glen Deloid; Steve Lenard; Natalie Fix; Yosuke Mizuyama; Toshiyuki Yamauchi; Joseph Brain; Philip Demokritou
Journal:  Environ Sci Nano       Date:  2014

4.  Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.

Authors:  Giuseppe Belardo; Orlando Cenciarelli; Simone La Frazia; Jean Francois Rossignol; M Gabriella Santoro
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

5.  Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines.

Authors:  Larry R Smith; Walter Wodal; Brian A Crowe; Astrid Kerschbaum; Peter Bruehl; Michael G Schwendinger; Helga Savidis-Dacho; Sean M Sullivan; Mark Shlapobersky; Jukka Hartikka; Alain Rolland; P Noel Barrett; Otfried Kistner
Journal:  Hum Vaccin Immunother       Date:  2013-03-06       Impact factor: 3.452

6.  Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.

Authors:  Chunlong Ma; Jiantao Zhang; Jun Wang
Journal:  Mol Pharmacol       Date:  2016-07-06       Impact factor: 4.436

7.  Recombinant immunoglobulin A specific for influenza A virus hemagglutinin: production, functional analysis, and formation of secretory immunoglobulin A.

Authors:  Kentaro Shoji; Tadanobu Takahashi; Kohta Kurohane; Koki Iwata; Takeshi Matsuoka; Shogo Tsuruta; Takatomo Sugino; Masaki Miyake; Takashi Suzuki; Yasuyuki Imai
Journal:  Viral Immunol       Date:  2015-02-06       Impact factor: 2.257

8.  Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza.

Authors:  Maria P Limberis; Virginie S Adam; Gary Wong; Jason Gren; Darwyn Kobasa; Ted M Ross; Gary P Kobinger; Anna Tretiakova; James M Wilson
Journal:  Sci Transl Med       Date:  2013-05-29       Impact factor: 17.956

9.  Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

Authors:  Ali H Ellebedy; Florian Krammer; Gui-Mei Li; Matthew S Miller; Christopher Chiu; Jens Wrammert; Cathy Y Chang; Carl W Davis; Megan McCausland; Rivka Elbein; Srilatha Edupuganti; Paul Spearman; Sarah F Andrews; Patrick C Wilson; Adolfo García-Sastre; Mark J Mulligan; Aneesh K Mehta; Peter Palese; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

10.  Influenza a virus entry: implications in virulence and future therapeutics.

Authors:  Emily Rumschlag-Booms; Lijun Rong
Journal:  Adv Virol       Date:  2013-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.